Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.74 USD | +2.96% | +2.35% | -67.87% |
14/05 | Transcript : GeoVax Labs, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
28/03 | GeoVax Labs, Inc. to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GEOVAX LABS, INC. | Other Biotechnology & Medical Research | +2.96% | +2.35% | -67.87% | -80.65% | -100.00% | 43.99L |
Technical Rankings Surperformance
- Stock Market
- Equities
- GOVX Stock
- Charts GeoVax Labs, Inc.
- Comparison Chart